|
1
|
Shimada T: Xenobiotic-metabolizing enzymes
involved in activation and detoxification of carcinogenic
polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet.
21:257–276. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elovaara E, Mikkola J, Stockmann-Juvala H,
Luukkanen L, Keski-Hynnilä H, Kostiainen R, Pasanen M, Pelkonen O
and Vainio H: Polycyclic aromatic hydrocarbon (PAH) metabolizing
enzyme activities in human lung, and their inducibility by exposure
to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene
as shown in the rat lung and liver. Arch Toxicol. 81:169–182. 2007.
View Article : Google Scholar
|
|
3
|
Agúndez JA: Cytochrome P450 gene
polymorphism and cancer. Curr Drug Metab. 5:211–224. 2004.
|
|
4
|
Shimada T and Fijii-Kuriyama Y: Metabolic
activation of polycyclic aromatic hydrocarbons to carcinogens by
cytochromes P450 1A1 and 1B1. Cancer Sci. 95:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wright CM, Larsen JE, Colosimo ML, Barr
JJ, Chen L, McLachlan RE, Yang IA, Bowman RV and Fong KM: Genetic
association study of CYP1A1 polymorphisms identifies risk
haplotypes in non-small cell lung cancer. Eur Respir J. 35:152–159.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang XR, Wacholder S, Xu Z, Dean M, Clark
V, Gold B, Brown LM, Stone BJ, Fraumeni JF and Caporaso NE: CYP1A1
and GSTM1 polymorphisms in relation to lung cancer risk in Chinese
women. Cancer Lett. 214:197–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sreeja L, Syamala V, Hariharan S, Madhavan
J, Devan SC and Ankathil R: Possible risk modification by CYP1A1,
GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in
a south Indian population. J Hum Genet. 50:618–627. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cha IH, Park JY, Chung WY, Choi MA, Kim HJ
and Park KK: Polymorphisms of CYP1A1 and GSTM1 genes and
susceptibility to oral cancer. Yonsei Med J. 48:233–239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Anantharaman D, Chaubal PM, Kannan S,
Bhisey RA and Mahimkar MB: Susceptibility to oral cancer by genetic
polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians:
tobacco exposure as a risk modulator. Carcinogenesis. 28:1455–1462.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chatarjee S, Chakrabarti S, Sengupta B,
Poddar S, Biswas D, Sengupta S and Taludker G: Prevalence of CYP1A1
and GST polymorphisms in the population of northeastern India and
susceptibility of oral cancer. Oncol Res. 17:397–403. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Acevedo C, Opazo JL, Huidobro C, Cabezas
J, Iturrieta J and Quiñones L: Positive correlation between single
or combined genotypes of CYP1A1 and GSTM1 in relation to prostate
cancer in Chilean people. Prostate. 57:111–117. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Little J, Sharp L, Masson LF, Brockton N,
Cotton S, Haites N and Cassidy J: Colorectal cancer and genetic
polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in
the Grampian region of Scotland. Int J Cancer. 119:2155–2164. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee K, Cáceres D, Varela N, Csendes A,
Ríos H and Quiñones L: Evaluation of CYP1A1 and GSTM1 as gastric
cancer susceptibility biomarkers: influence of smoking habit and
alcohol consumption. Rev Med Chil. 134:1107–1115. 2006.PubMed/NCBI
|
|
14
|
Kiss I, Orsós Z, Gombos K, Bogner B,
Csejtei A, Tibold A, Varga Z, Pázsit E, Magda I, Zölyomi A and
Ember I: Association between allelic polymorphisms of metabolizing
enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of
colorectal cancer in Hungary. Anticancer Res. 27:2931–2937.
2007.PubMed/NCBI
|
|
15
|
Quiñones L and Gil L: Induction of rat
hepatic cytochrome P450 1A1 isozyme by organic extracts from
airborne particulate matter. Xenobiotica. 25:571–579. 1995.
|
|
16
|
Kawajiri K, Watanabe J, Gotoh O, Tagashira
Y, Sowaga K and Fujii-Kuriyama Y: Structure and drug inducibility
of human cytochrome P450c gene. Eur J Biochem. 159:219–225. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kawajiri K, Nakachi K, Imai A, Yoshu N,
Shimada J and Watanabe J: Identification of genetically high risk
individuals to oral cancer by DNA polymorphisms of the cytochrome
P4501A1 gene. FEBS Lett. 263:131–133. 1990. View Article : Google Scholar
|
|
18
|
Hayashi S, Watanabe J, Nakachi K and
Kawajiri K: PCR detection of an A/G polymorphism within exon 7 of
the CYP1A1 gene. Nucleic Acids Res. 19:47971991. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Crofts F, Cosma G, Currie D, Taioli E,
Toniolo P and Garte S: A novel, CYP1A1 gene polymorphism in
African-Americans. Carcinogenesis. 14:29–31. 1993.PubMed/NCBI
|
|
20
|
Cascorbi L, Brockmoller J and Roots L: A
C4887A polymorphism in exon 7 of human CYP1A1: population
frequency, mutation linkages and impact on oral cancer
susceptibility. Cancer Res. 56:4965–4969. 1996.PubMed/NCBI
|
|
21
|
Aynacioglu A, Cascorbi I, Ozikiewicz P and
Roots I: High frequency of CYP1A1 mutations in a Turkish
population. Arch Toxicol. 72:215–218. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Magno LA, Talbot J, Talbot T, Borges
Santos AM, Souza RP, Marin LJ, Moreli ML, de Melo PR, Corrêa RX,
Rios Santos F and Di Pietro G: Glutathione s-transferase variants
in a brazilian population. Pharmacology. 83:231–236. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bailliet G, Santos MR, Alfaro EL, Dipierri
JE, Demarchi DA, Carnese FR and Bianchi NO: Allele and genotype
frequencies of metabolic genes in Native Americans from Argentina
and Paraguay. Mutat Res. 627:171–177. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Torres MM, Acosta CP, Sicard DM and Groot
de Restrepo H: Genetic susceptibility and risk of gastric cancer in
a human population of Cauca, Colombia. Biomedica. 24:153–162.
2004.PubMed/NCBI
|
|
25
|
Quiñones L, Berthou F, Varela N, Simon B,
Gil L and Lucas D: Ethnic susceptibility to lung cancer:
differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms
between French Caucasian and Chilean populations. Cancer Lett.
141:167–171. 1999.PubMed/NCBI
|
|
26
|
Seidegard J, Vorachek W, Pero R and
Pearson W: Hereditary differences in the expression of the human
glutathione transferase active on trans-stilbene oxide are due to a
gene deletion. Proc Natl Acad Sci USA. 85:7293–7297. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin H-J, Han C-Y, Bernstein DA, Hsiao W,
Lin B and Hardy S: Ethnic distribution of the glutathione
transferase Mu 1–1 (GSTM1) null genotype in 1473 individuals and
application to bladder cancer susceptibility. Carcinogenesis.
15:1077–1081. 1994.
|
|
28
|
Linhares JJ, Da Silva ID, De Souza NC,
Noronha EC, Ferraro O, De Carvallo CV and Bacarat FF: Genetic
polymorphism of GSTM1 in women with breast cancer and interact with
reproductive history and several clinical pathologies. Biol Res.
38:273–281. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boccia S, Sayed-Tabatabaei FA, Persiani R,
Gianfagna F, Rausei S, Arzani D, La Greca A, D’Ugo D, La Torre G,
van Duijn CM and Ricciardi G: Polymorphisms in metabolic genes,
their combination and interaction with tobacco smoke and alcohol
consumption and risk of gastric cancer: a case-control study in an
Italian population. BMC Cancer. 7:2062007. View Article : Google Scholar
|
|
30
|
Quiñones L, Lucas D, Godoy J, Cáceres D,
Berthou F, Varela N, Lee K, Acevedo C, Martínez L, Aguilera AM and
Gil L: CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect
of single and combined genotypes on lung cancer susceptibility in
chilean people. Cancer Lett. 174:35–44. 2001.PubMed/NCBI
|
|
31
|
Lira MG, Provezza L, Malerba G, Naldi L,
Remuzzi G, Boschiero L, Forni A, Rugiu C, Piaserico S, Alaibac M,
Turco A, Girolomoni G and Tessari G: Glutathione S-transferase and
CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in
Italian transplanted patients. Exp Dermatol. 15:958–965. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yoshida K, Osawa K, Kasahara M, Miyaishi
A, Nakanishi K, Hayamizu S, Osawa Y, Tsutou A, Tabuchi Y, Shimada
E, Tanaka K, Yamamoto M and Takahashi J: Association of CYP1A1,
CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer
and smoking. Asian Pac J Cancer Prev. 8:438–444. 2007.PubMed/NCBI
|
|
33
|
Caceres D, Iturrieta J, Acevedo C,
Huidobro C, Varela N and Quiñones L: Relationship among
metabolizing genes, smoking and alcohol use as modifier factors on
prostate cancer risk: Exploring some gene-gene and gene-environment
interactions. Eur J Epidemiol. 20:79–88. 2005. View Article : Google Scholar
|
|
34
|
Das BR and Nagpal JK: Understanding the
biology of oral cancer. Med Sci Monit. 8:RA258–267. 2002.PubMed/NCBI
|
|
35
|
Riera P and Martínez B: Morbidity and
mortality for oral and pharyngeal cancer in Chile. Rev Med Chil.
133:555–563. 2005.PubMed/NCBI
|
|
36
|
Ambrosone C, Freudenheim J, Oraham S,
Marshall J, Vena J, Brasure J, Laughlin R, Nemoto T, Michalek A,
Harrington A, Ford T and Shields P: Cytochrome P4501A1 and
glutathione S-transferase (Ml) genetic polymorphisms and
postmenopausal breast cancer risk. Cancer Res. 55:3483–3485.
1995.PubMed/NCBI
|
|
37
|
Garte S: The role of ethnicity in cancer
susceptibility gene polymorphisms: the example of CYP1A1.
Carcinogenesis. 19:1329–1332. 1998. View Article : Google Scholar : PubMed/NCBI
|
